Phillip G. Febbo insider trades

Open-market stock purchases and sales by Phillip G. Febbo, Chief Scientific & Med Officer at Veracyte, Inc, from SEC Form 4 filings since Aug 15, 2015.

Recent trades

DateStockTradeValue
Sep 4, 2026VCYT Veracyte, IncSold$446K
Sep 4, 2026VCYT Veracyte, IncSold$118K
Sep 2, 2026VCYT Veracyte, IncSold (not open market)$163K
Jun 2, 2026VCYT Veracyte, IncSold (not open market)$178K
Mar 6, 2026VCYT Veracyte, IncBought (not open market)—
Mar 6, 2026VCYT Veracyte, IncBought (not open market)—
Mar 2, 2026VCYT Veracyte, IncSold (not open market)$217K
Mar 2, 2026VCYT Veracyte, IncSold$485K
Feb 26, 2026VCYT Veracyte, IncBought (not open market)—
Feb 26, 2026VCYT Veracyte, IncSold (not open market)$949K
Dec 2, 2025VCYT Veracyte, IncSold (not open market)$136K
Oct 6, 2025VCYT Veracyte, IncSold$301K

Companies traded

  • VCYT Veracyte, Inc: 7 sales, last Sep 4, 2026
  • ILMN Illumina, Inc: 8 sales, last Mar 1, 2023
  • VAR Varian Medical Systems Inc: other filings, last Apr 15, 2021
  • GHDX Genomic Health Inc: 10 sales, last Feb 20, 2018

Get free alerts when Phillip G. Febbo files a new trade →